Developer docs
API playgroundTry for free, no card

Search company profiles

Laboratorios Normon Sa

Full company profile

uuid02lwy7b

Namestring
Laboratorios Normon Sa
Legal namestring
Laboratorios Normon, S.A.
Websiteurl
normon.com
Company typeenum
Private
Founded yearint
1937
Descriptiontext

Laboratorios Normon, S.A. is a privately held Spanish pharmaceutical manufacturer founded in 1938 and headquartered in Tres Cantos, Madrid, where it operates one of the largest drug manufacturing complexes in Europe at over 100,000 m2. The company develops, manufactures, and markets generic medicines, dental products, and self-care (OTC) pharmaceuticals across five operating divisions: Generics, Hospitals, Dental, Self-care (Normon Contigo), and International. Its portfolio spans 340 active ingredients, 236 of which are commercialized as generics in over 1,200 presentations, 200+ dental SKUs led by the Ultracain anesthetic (launched 1992), and 188+ self-care products including the Bensania natural line. Normon was the pioneer of generic medicines in Spain, launching the first three generics and conducting the first bioequivalence study in 1997, and holds the #4 position in the total Spanish pharmaceutical market with 18.8% retail unit share, 19.1% hospital unit share, and 61.2% of the Spanish dental anesthetic market.

The business is monetized through prescription generic sales via retail pharmacies, direct hospital procurement, dental channel distribution, OTC self-care sales via the normoncontigo platform, and international revenues from 90+ countries generated through subsidiaries, licensing/supply agreements, and CMO services. Production scale reaches 4,966 million doses and 345+ million units annually, supported by 3,200+ professionals, dedicated capabilities in penicillin, cephalosporin, and high-containment/cytotoxic manufacturing, and a regulatory stack that includes EU GMP, US FDA approval (granted 2016 for sterile liquid vials), GLP, and six ISO certifications (9001, 14001, 13485, 20000, 27001, 27701). GTM motion is sales-led through healthcare professionals, pharmacies, hospitals, and dental practitioners domestically, paired with channel-partner and CMO-led internationalization abroad.

Recent strategic activity has emphasized consumer-health diversification (Bensania natural line 2024, new prescription packaging 2024), continued capacity expansion at the Tres Cantos campus, and FDA-enabled US market positioning, while remaining independently owned with no disclosed venture, private equity, or public-market backing and growing organically through reinvested profits.

Short descriptiontext

Laboratorios Normon is a privately held Spanish pharmaceutical company that develops, manufactures, and markets generic medicines, dental products, and OTC self-care pharmaceuticals, serving retail pharmacies, hospitals, dental practitioners, and international partners across 90+ countries from its Tres Cantos, Madrid manufacturing complex.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersTres Cantos, Spain
HQ citystring
Tres Cantos
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic medicines, dental anesthetics, hospital injectables, OTC self-care, contract manufacturing
Industry3 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Prescription generic pharmaceuticals
TypeOne Time License
Description

Normon's core revenue stream from prescription generic medicines. The company is a pioneer in generic drugs in Spain (launched first generics in 1997) and holds leading market positions. The generics division covers 236 active ingredients in over 1,200 presentations across key therapeutic areas.

normon.com
2Hospital pharmaceutical products
TypeOne Time License
Description

Supply of oral and parenteral pharmaceutical products to hospitals and clinics across Spain. Normon holds 19.1% hospital units market share in Spain and supplies 19% of total doses.

normon.com
3Dental pharmaceutical products
TypeOne Time License
Description

Dental division products including Ultracain anesthetic (launched 1992), with Normon supplying anesthesia to one in two patients in Spain and holding 61.2% of the Spanish dental anesthetic market.

normon.com
4Self-care and OTC products
TypeOne Time License
Description

Over-the-counter medicines and self-care products sold directly to consumers through pharmacy channels. Includes brands such as Bensania (natural products), Abrilia, Normomar, KitaPic, and Bucomed. Over 188 self-care products marketed.

normoncontigo.normon.com
5International exports and CMO services
TypeLicensing Royalties
Description

International division managing exports to 90+ countries, with licensing and supply agreements, internationalization of Normon products, and Contract Manufacturing Organization (CMO) services for third parties.

normon.com
6Professional services and training
TypeProfessional Services
Description

Congress and training course management through Club Normonclass, including continuing education for healthcare professionals.

normon.com
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Bensania
Description

Natural line of products made with natural ingredients, including royal jelly, probiotics, and CBD-based products for circulation, digestion, energy, stress, sleep, and respiratory health.

normoncontigo.normon.com
+7 more records
Core offering1 text field

Laboratorios Normon is a Spanish pharmaceutical manufacturer that develops, produces, and markets generic prescription medicines, sterile hospital pharmaceutical products, dental specialty products (notably dental anesthetics including the Ultracain brand), and over-the-counter self-care products. The company operates multiple manufacturing facilities producing sterile injectables, oral solids, and topical formulations, and serves retail pharmacy, hospital, dental, and international healthcare channels across 90+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Generic drugs save the Spanish National Health System (SNS) €1 billion per year.
+5 more records
Product overview1 text field

Laboratorios Normon Sa operates as a pharmaceutical company with a diversified portfolio organized into five main divisions: Generics (pioneers in Spain since 1997 with 236+ active ingredients in 1,200+ presentations), Hospitals (oral and parenteral products in all Spanish clinics), Dental (200+ products including Ultracain anesthetic), Self-care/OTC (Normon Contigo platform with Bensania natural line and other brands), and International. The company also offers a digital prescription service (recetariobucomed.normon.com) for healthcare professionals. Products range from prescription pharmaceuticals to OTC self-care solutions and medical devices.

Product and service6 records
1Generic Prescription Medicines (Division Genericos)
CategoryGeneric prescription pharmaceuticals
Description

Broad portfolio of generic prescription pharmaceutical products across multiple therapeutic areas, distributed through retail pharmacy wholesale, hospital pharmacy procurement, and international healthcare channels.

2Hospital Medicines (Division Hospitales)
CategoryHospital pharmaceuticals
Description

Sterile injectable and hospital-formulated pharmaceutical products supplied to hospital pharmacy procurement departments across public and private healthcare facilities, leveraging Normon's sterile manufacturing capabilities.

3Dental Pharmaceutical Products (Division Dental, incl. Ultracain)
CategoryDental pharmaceuticals
Description

Specialty dental pharmaceutical portfolio anchored by the Ultracain brand of dental anesthetics (articaine-based), supplied to dental practitioners; Normon holds a leading share of the Spanish dental anesthetic market.

4Self-Care / OTC Consumer Products (Normon Contigo)
CategoryOTC consumer health
Description

Over-the-counter self-care product line covering common therapeutic categories such as pain relief and sleep aids, marketed under the Normon Contigo brand via retail pharmacies and own e-commerce channels.

5Pharmaceutical Contract Manufacturing (CMO) Services
CategoryPharmaceutical manufacturing services
Description

Third-party contract development and manufacturing services covering sterile liquids, oral solids, topical formulations, and cytotoxic high-containment production for external pharmaceutical clients, supported by Normon's FDA-approved manufacturing footprint.

6International Export and Licensing (Division Internacional)
CategoryInternational pharmaceutical distribution and licensing
Description

Distribution of Normon products to 90+ countries through export, partnership, agency, and licensing arrangements for healthcare systems and distributors outside Spain.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Slovenian generic pharmaceutical manufacturer with strong CEE and Western European hospital penetration — comparable to Normon's hospital-channel focus, generics portfolio breadth, and export-driven growth.

TypeDirect peer
Description

Spanish pharmaceutical and OTC company with prescription, hospital, and consumer health divisions — directly comparable as a Spanish pharma across similar Rx/hospital/OTC channels.

3Sandoz (Novartis)
TypeBroad incumbent
Description

European-headquartered global generics leader following its Novartis spin-off; comparable to Normon in European generic manufacturing, hospital-channel focus, and regulated-market expertise.

TypeBroad incumbent
Description

Global broad pharmaceutical incumbent with significant European generics, OTC, and specialty operations — comparable in scale and European regulatory footprint though much broader than Normon's generics focus.

TypeDirect peer
Description

Spanish pharmaceutical company focused on dermatology and specialty pharma with European commercial footprint — comparable as a Spanish-headquartered pharma with international commercial operations.

TypeDirect peer
Description

European-focused generics and consumer healthcare company headquartered in Germany — directly comparable to Normon's European generics, OTC/self-care, and licensing-driven international model.

TypeDirect peer
Description

Spanish specialty pharmaceutical company with hospital-channel focus, injectable manufacturing, and international growth — directly comparable as a Spanish-headquartered pharma with similar export ambitions.

TypeBroad incumbent
Description

World's largest generic pharmaceutical manufacturer with a broad portfolio across therapeutic areas and CMO services — directly comparable to Normon in generics scale, FDA-approved manufacturing, and global distribution reach.

TypeBroad incumbent
Description

Global generics and specialty pharma company with deep European and emerging-market presence — overlaps with Normon's generics portfolio, international footprint, and hospital channel.

TypeDirect peer
Description

European generics manufacturer with strong presence in CEE, France, and Italy — comparable to Normon's European generics focus, hospital-channel emphasis, and multi-country distribution model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laboratorios Normon Sa

Generic Pharmaceuticalsnormon.com

Laboratorios Normon is a privately held Spanish pharmaceutical company that develops, manufactures, and markets generic medicines, dental products, and OTC self-care pharmaceuticals, serving retail pharmacies, hospitals, dental practitioners, and international partners across 90+ countries from its Tres Cantos, Madrid manufacturing complex.

What Laboratorios Normon Sa does

Laboratorios Normon, S.A. is a privately held Spanish pharmaceutical manufacturer founded in 1938 and headquartered in Tres Cantos, Madrid, where it operates one of the largest drug manufacturing complexes in Europe at over 100,000 m2. The company develops, manufactures, and markets generic medicines, dental products, and self-care (OTC) pharmaceuticals across five operating divisions: Generics, Hospitals, Dental, Self-care (Normon Contigo), and International. Its portfolio spans 340 active ingredients, 236 of which are commercialized as generics in over 1,200 presentations, 200+ dental SKUs led by the Ultracain anesthetic (launched 1992), and 188+ self-care products including the Bensania natural line. Normon was the pioneer of generic medicines in Spain, launching the first three generics and conducting the first bioequivalence study in 1997, and holds the #4 position in the total Spanish pharmaceutical market with 18.8% retail unit share, 19.1% hospital unit share, and 61.2% of the Spanish dental anesthetic market.

The business is monetized through prescription generic sales via retail pharmacies, direct hospital procurement, dental channel distribution, OTC self-care sales via the normoncontigo platform, and international revenues from 90+ countries generated through subsidiaries, licensing/supply agreements, and CMO services. Production scale reaches 4,966 million doses and 345+ million units annually, supported by 3,200+ professionals, dedicated capabilities in penicillin, cephalosporin, and high-containment/cytotoxic manufacturing, and a regulatory stack that includes EU GMP, US FDA approval (granted 2016 for sterile liquid vials), GLP, and six ISO certifications (9001, 14001, 13485, 20000, 27001, 27701). GTM motion is sales-led through healthcare professionals, pharmacies, hospitals, and dental practitioners domestically, paired with channel-partner and CMO-led internationalization abroad.

Recent strategic activity has emphasized consumer-health diversification (Bensania natural line 2024, new prescription packaging 2024), continued capacity expansion at the Tres Cantos campus, and FDA-enabled US market positioning, while remaining independently owned with no disclosed venture, private equity, or public-market backing and growing organically through reinvested profits.

Laboratorios Normon Sa firmographics

Firmographics
Name
Laboratorios Normon Sa
Legal name
Laboratorios Normon, S.A.
Website
https://normon.com
Company type
Private
Founded year
1937
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Laboratorios Normon is a privately held Spanish pharmaceutical company that develops, manufactures, and markets generic medicines, dental products, and OTC self-care pharmaceuticals, serving retail pharmacies, hospitals, dental practitioners, and international partners across 90+ countries from its Tres Cantos, Madrid manufacturing complex.
Ownership category
akta.pro rank

Laboratorios Normon Sa industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services

Keywords

  • Generic medicines
  • Dental anesthetics
  • Hospital injectables
  • OTC self-care
  • Contract manufacturing

Where Laboratorios Normon Sa is headquartered

Location

Headquarters

HQ city
Tres Cantos
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

Laboratorios Normon Sa business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Prescription generic pharmaceuticals: Normon's core revenue stream from prescription generic medicines. The company is a pioneer in generic drugs in Spain (launched first generics in 1997) and holds leading market positions. The generics division covers 236 active ingredients in over 1,200 presentations across key therapeutic areas.
  2. Hospital pharmaceutical products: Supply of oral and parenteral pharmaceutical products to hospitals and clinics across Spain. Normon holds 19.1% hospital units market share in Spain and supplies 19% of total doses.
  3. Dental pharmaceutical products: Dental division products including Ultracain anesthetic (launched 1992), with Normon supplying anesthesia to one in two patients in Spain and holding 61.2% of the Spanish dental anesthetic market.
  4. Self-care and OTC products: Over-the-counter medicines and self-care products sold directly to consumers through pharmacy channels. Includes brands such as Bensania (natural products), Abrilia, Normomar, KitaPic, and Bucomed. Over 188 self-care products marketed.
  5. International exports and CMO services: International division managing exports to 90+ countries, with licensing and supply agreements, internationalization of Normon products, and Contract Manufacturing Organization (CMO) services for third parties.
  6. Professional services and training: Congress and training course management through Club Normonclass, including continuing education for healthcare professionals.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels11 records

Laboratorios Normon Sa product offering

Product offering

Core offering

Laboratorios Normon is a Spanish pharmaceutical manufacturer that develops, produces, and markets generic prescription medicines, sterile hospital pharmaceutical products, dental specialty products (notably dental anesthetics including the Ultracain brand), and over-the-counter self-care products. The company operates multiple manufacturing facilities producing sterile injectables, oral solids, and topical formulations, and serves retail pharmacy, hospital, dental, and international healthcare channels across 90+ countries.

Product overview

Laboratorios Normon Sa operates as a pharmaceutical company with a diversified portfolio organized into five main divisions: Generics (pioneers in Spain since 1997 with 236+ active ingredients in 1,200+ presentations), Hospitals (oral and parenteral products in all Spanish clinics), Dental (200+ products including Ultracain anesthetic), Self-care/OTC (Normon Contigo platform with Bensania natural line and other brands), and International. The company also offers a digital prescription service (recetariobucomed.normon.com) for healthcare professionals. Products range from prescription pharmaceuticals to OTC self-care solutions and medical devices.

Differentiator

Problem solved

Functional benefit

Brands

  • Bensania: Natural line of products made with natural ingredients, including royal jelly, probiotics, and CBD-based products for circulation, digestion, energy, stress, sleep, and respiratory health.
  • Normon Contigo
  • Club NormonClass
  • Ultracain
  • Abrilia
  • Normomar
  • KitaPic
  • Bucomed

Products and services

  • Generic Prescription Medicines (Division Genericos) Broad portfolio of generic prescription pharmaceutical products across multiple therapeutic areas, distributed through retail pharmacy wholesale, hospital pharmacy procurement, and international healthcare channels.
  • Hospital Medicines (Division Hospitales) Sterile injectable and hospital-formulated pharmaceutical products supplied to hospital pharmacy procurement departments across public and private healthcare facilities, leveraging Normon's sterile manufacturing capabilities.
  • Dental Pharmaceutical Products (Division Dental, incl. Ultracain) Specialty dental pharmaceutical portfolio anchored by the Ultracain brand of dental anesthetics (articaine-based), supplied to dental practitioners; Normon holds a leading share of the Spanish dental anesthetic market.
  • Self-Care / OTC Consumer Products (Normon Contigo) Over-the-counter self-care product line covering common therapeutic categories such as pain relief and sleep aids, marketed under the Normon Contigo brand via retail pharmacies and own e-commerce channels.
  • Pharmaceutical Contract Manufacturing (CMO) Services Third-party contract development and manufacturing services covering sterile liquids, oral solids, topical formulations, and cytotoxic high-containment production for external pharmaceutical clients, supported by Normon's FDA-approved manufacturing footprint.
  • International Export and Licensing (Division Internacional) Distribution of Normon products to 90+ countries through export, partnership, agency, and licensing arrangements for healthcare systems and distributors outside Spain.

Quantifiable outcome

  • Generic drugs save the Spanish National Health System (SNS) €1 billion per year.
  • +5 more outcomes

Companies that use Laboratorios Normon Sa

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Laboratorios Normon Sa technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Laboratorios Normon Sa partnerships and signals

Strategic signal

Scale indicators17 records

Recent moves10 records

Expansion highlights5 records

Laboratorios Normon Sa competitors and assessment

Company assessment

Direct peers

  • Krka: Slovenian generic pharmaceutical manufacturer with strong CEE and Western European hospital penetration — comparable to Normon's hospital-channel focus, generics portfolio breadth, and export-driven growth.
  • Faes Farma: Spanish pharmaceutical and OTC company with prescription, hospital, and consumer health divisions — directly comparable as a Spanish pharma across similar Rx/hospital/OTC channels.
  • Almirall: Spanish pharmaceutical company focused on dermatology and specialty pharma with European commercial footprint — comparable as a Spanish-headquartered pharma with international commercial operations.
  • Stada Arzneimittel: European-focused generics and consumer healthcare company headquartered in Germany — directly comparable to Normon's European generics, OTC/self-care, and licensing-driven international model.
  • Laboratorios Rovi: Spanish specialty pharmaceutical company with hospital-channel focus, injectable manufacturing, and international growth — directly comparable as a Spanish-headquartered pharma with similar export ambitions.
  • Zentiva: European generics manufacturer with strong presence in CEE, France, and Italy — comparable to Normon's European generics focus, hospital-channel emphasis, and multi-country distribution model.

Broad incumbents

  • Sandoz (Novartis): European-headquartered global generics leader following its Novartis spin-off; comparable to Normon in European generic manufacturing, hospital-channel focus, and regulated-market expertise.
  • Sanofi: Global broad pharmaceutical incumbent with significant European generics, OTC, and specialty operations — comparable in scale and European regulatory footprint though much broader than Normon's generics focus.
  • Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with a broad portfolio across therapeutic areas and CMO services — directly comparable to Normon in generics scale, FDA-approved manufacturing, and global distribution reach.
  • Viatris (Mylan-Upjohn): Global generics and specialty pharma company with deep European and emerging-market presence — overlaps with Normon's generics portfolio, international footprint, and hospital channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Laboratorios Normon Sa social profiles

Digital presence

Laboratorios Normon Sa compliance and trust

Trust signal

Compliance8 records

Laboratorios Normon Sa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laboratorios Normon Sa leadership team

Management profile

Number of profiles

Laboratorios Normon Sa funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laboratorios Normon Sa M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Normon Sa

What does Laboratorios Normon Sa do?

Laboratorios Normon is a Spanish pharmaceutical manufacturer that develops, produces, and markets generic prescription medicines, sterile hospital pharmaceutical products, dental specialty products (notably dental anesthetics including the Ultracain brand), and over-the-counter self-care products. The company operates multiple manufacturing facilities producing sterile injectables, oral solids, and topical formulations, and serves retail pharmacy, hospital, dental, and international healthcare channels across 90+ countries.

Is Laboratorios Normon Sa a public or private company?

Laboratorios Normon Sa is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Laboratorios Normon Sa founded?

Laboratorios Normon Sa was founded in 1937. It employs 1,001 to 5,000 people.

Where is Laboratorios Normon Sa based?

Laboratorios Normon Sa is headquartered in Tres Cantos, Spain, in the Europe region.

How does Laboratorios Normon Sa make money?

Six revenue lines are on record. Prescription generic pharmaceuticals are the primary driver. The others are hospital pharmaceutical products, dental pharmaceutical products, self-care and OTC products, international exports and CMO services and professional services and training.

Who are Laboratorios Normon Sa's main competitors?

Direct peers on record are Krka, Faes Farma, Almirall, Stada Arzneimittel, Laboratorios Rovi and Zentiva. Broad incumbents are Sandoz (Novartis), Sanofi, Teva Pharmaceutical Industries and Viatris (Mylan-Upjohn).

Does Laboratorios Normon Sa have an API?

No public API is recorded for Laboratorios Normon Sa.

What industry is Laboratorios Normon Sa in?

Laboratorios Normon Sa's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales